GeniPhys
Indianapolis, US · Founded 2021 · Delaware corporation · 1 known investors
GeniPhys develops Collymer, a patented polymerizable (scaffold-forming) collagen technology used to design and fabricate collagen biomaterials for tissue restoration and regeneration. Its materials target regenerative medicine applications including soft tissue, cardiovascular, musculoskeletal, and orthopedic replacements, as well as delivery of pharmaceutical and cell-based therapies and device coatings.
Founders & leadership
GeniPhys was founded in 2021 by Sherry L. Harbin and Sherry Harbin.
SL
Sherry L. HarbinCo-founder
SH
Sherry HarbininFounder
AS
Andrew S. EiblingExecutive
SA
Scot A. HarbinNamed on SEC filing
Board
SH
Shaun HawkinsBoard director
JD
John DeFordBoard director
RM
R. Matthew NeffBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.5M disclosed across 2 rounds · 2022–2026
▶$3MraisedFeb 2026 · 17 investors · Other Health CareRule 506(b)
▶$3MraisedFeb 2026 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John DeFordDirector
- Shaun HawkinsDirector
- Andrew S EiblingExecutive Officer, Director
- R. Matthew NeffDirector
- Offering amount
- $5.5M
- Amount sold
- $3M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$4.5MraisedNov 2022 · 25 investors · Other Health CareRule 506(b)
▶$4.5MraisedNov 2022 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sherry L. HarbinExecutive Officer, Director
- Scot A. HarbinExecutive Officer
- R. Matthew NeffDirector
- Andrew S. EiblingExecutive Officer, Director
- Offering amount
- $6.1M
- Amount sold
- $4.5M
- Minimum investment
- $25K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does GeniPhys do?
- GeniPhys develops Collymer, a patented polymerizable (scaffold-forming) collagen technology used to design and fabricate collagen biomaterials for tissue restoration and regeneration. Its materials target regenerative medicine applications including soft tissue, cardiovascular, musculoskeletal, and orthopedic replacements, as well as delivery of pharmaceutical and cell-based therapies and device coatings.
- Who founded GeniPhys?
- GeniPhys was founded by Sherry L. Harbin, Sherry Harbin in 2021.
- Who are GeniPhys's investors?
- GeniPhys's investors include Elevate Ventures.
- How much funding has GeniPhys raised?
- GeniPhys has disclosed $7.5M raised across 2 rounds.
- Where is GeniPhys headquartered?
- GeniPhys is headquartered in Indianapolis, US.